Logo image of EXAI.MI

EXPERT.AI SPA (EXAI.MI) Stock Fundamental Analysis

Europe - BIT:EXAI - IT0004496029 - Common Stock

1.418 EUR
0 (-0.28%)
Last: 11/12/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EXAI. EXAI was compared to 111 industry peers in the Software industry. EXAI may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, EXAI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

EXAI had negative earnings in the past year.
In the past year EXAI has reported a negative cash flow from operations.
In the past 5 years EXAI always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: EXAI reported negative operating cash flow in multiple years.
EXAI.MI Yearly Net Income VS EBIT VS OCF VS FCFEXAI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -20.72%, EXAI is doing worse than 82.88% of the companies in the same industry.
EXAI's Return On Equity of -55.60% is on the low side compared to the rest of the industry. EXAI is outperformed by 82.88% of its industry peers.
Industry RankSector Rank
ROA -20.72%
ROE -55.6%
ROIC N/A
ROA(3y)-17.14%
ROA(5y)-11.81%
ROE(3y)-30.65%
ROE(5y)-21.46%
ROIC(3y)N/A
ROIC(5y)N/A
EXAI.MI Yearly ROA, ROE, ROICEXAI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

EXAI has a better Gross Margin (82.85%) than 76.58% of its industry peers.
In the last couple of years the Gross Margin of EXAI has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for EXAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5Y1.01%
EXAI.MI Yearly Profit, Operating, Gross MarginsEXAI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

3

2. Health

2.1 Basic Checks

EXAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EXAI has been increased compared to 1 year ago.
The number of shares outstanding for EXAI has been increased compared to 5 years ago.
EXAI has a better debt/assets ratio than last year.
EXAI.MI Yearly Shares OutstandingEXAI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
EXAI.MI Yearly Total Debt VS Total AssetsEXAI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 0.78, we must say that EXAI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.78, EXAI is doing worse than 77.48% of the companies in the same industry.
EXAI has a Debt/Equity ratio of 0.52. This is a neutral value indicating EXAI is somewhat dependend on debt financing.
EXAI's Debt to Equity ratio of 0.52 is on the low side compared to the rest of the industry. EXAI is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 0.78
ROIC/WACCN/A
WACC8.24%
EXAI.MI Yearly LT Debt VS Equity VS FCFEXAI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

EXAI has a Current Ratio of 1.77. This is a normal value and indicates that EXAI is financially healthy and should not expect problems in meeting its short term obligations.
EXAI's Current ratio of 1.77 is fine compared to the rest of the industry. EXAI outperforms 66.67% of its industry peers.
EXAI has a Quick Ratio of 1.77. This is a normal value and indicates that EXAI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.77, EXAI is in the better half of the industry, outperforming 69.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77
EXAI.MI Yearly Current Assets VS Current LiabilitesEXAI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 56.15% over the past year.
EXAI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.83%.
EXAI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.05% yearly.
EPS 1Y (TTM)56.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.83%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y-3.77%
Revenue growth 5Y-9.05%
Sales Q2Q%30.88%

3.2 Future

Based on estimates for the next years, EXAI will show a very strong growth in Earnings Per Share. The EPS will grow by 33.21% on average per year.
Based on estimates for the next years, EXAI will show a very strong growth in Revenue. The Revenue will grow by 21.03% on average per year.
EPS Next Y90.91%
EPS Next 2Y44.6%
EPS Next 3Y33.21%
EPS Next 5YN/A
Revenue Next Year39.19%
Revenue Next 2Y26.95%
Revenue Next 3Y21.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXAI.MI Yearly Revenue VS EstimatesEXAI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
EXAI.MI Yearly EPS VS EstimatesEXAI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2 -0.3

1

4. Valuation

4.1 Price/Earnings Ratio

EXAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
EXAI is valuated quite expensively with a Price/Forward Earnings ratio of 139.02.
62.16% of the companies in the same industry are cheaper than EXAI, based on the Price/Forward Earnings ratio.
EXAI's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 34.43.
Industry RankSector Rank
PE N/A
Fwd PE 139.02
EXAI.MI Price Earnings VS Forward Price EarningsEXAI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

EXAI's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31.9
EXAI.MI Per share dataEXAI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

EXAI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as EXAI's earnings are expected to grow with 33.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.6%
EPS Next 3Y33.21%

0

5. Dividend

5.1 Amount

No dividends for EXAI!.
Industry RankSector Rank
Dividend Yield N/A

EXPERT.AI SPA

BIT:EXAI (11/12/2025, 7:00:00 PM)

1.418

0 (-0.28%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-30 2025-09-30
Earnings (Next)N/A N/A
Inst Owners3.15%
Inst Owner ChangeN/A
Ins Owners8.77%
Ins Owner ChangeN/A
Market Cap157.97M
Revenue(TTM)23.00M
Net Income(TTM)-13.96M
Analysts42.22
Price Target1.43 (0.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-133.33%
EPS NY rev (3m)-150%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 139.02
P/S 6.87
P/FCF N/A
P/OCF N/A
P/B 6.29
P/tB 20.58
EV/EBITDA 31.9
EPS(TTM)-0.14
EYN/A
EPS(NY)0.01
Fwd EY0.72%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.21
BVpS0.23
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.72%
ROE -55.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.85%
FCFM N/A
ROA(3y)-17.14%
ROA(5y)-11.81%
ROE(3y)-30.65%
ROE(5y)-21.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5Y1.01%
F-Score4
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA 2.58
Cap/Depr 89.47%
Cap/Sales 32.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z 0.78
F-Score4
WACC8.24%
ROIC/WACCN/A
Cap/Depr(3y)100.55%
Cap/Depr(5y)114.56%
Cap/Sales(3y)34.83%
Cap/Sales(5y)34.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.83%
EPS Next Y90.91%
EPS Next 2Y44.6%
EPS Next 3Y33.21%
EPS Next 5YN/A
Revenue 1Y (TTM)11.83%
Revenue growth 3Y-3.77%
Revenue growth 5Y-9.05%
Sales Q2Q%30.88%
Revenue Next Year39.19%
Revenue Next 2Y26.95%
Revenue Next 3Y21.03%
Revenue Next 5YN/A
EBIT growth 1Y-441.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year346.15%
EBIT Next 3Y78.82%
EBIT Next 5Y66.89%
FCF growth 1Y-217.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-235.78%
OCF growth 3YN/A
OCF growth 5YN/A

EXPERT.AI SPA / EXAI.MI FAQ

What is the fundamental rating for EXAI stock?

ChartMill assigns a fundamental rating of 2 / 10 to EXAI.MI.


Can you provide the valuation status for EXPERT.AI SPA?

ChartMill assigns a valuation rating of 1 / 10 to EXPERT.AI SPA (EXAI.MI). This can be considered as Overvalued.


Can you provide the profitability details for EXPERT.AI SPA?

EXPERT.AI SPA (EXAI.MI) has a profitability rating of 1 / 10.


Can you provide the financial health for EXAI stock?

The financial health rating of EXPERT.AI SPA (EXAI.MI) is 3 / 10.